Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study)

BACKGROUND: It is well known that the standard doses of a given drug may not have equivalent effects in all patients. To date, the management of depression remains mainly empirical and often poorly evaluated. The development of a personalized medicine in psychiatry may reduce treatment failure, into...

Descripción completa

Detalles Bibliográficos
Autores principales: Lloret-Linares, Célia, Daali, Youssef, Chevret, Sylvie, Nieto, Isabelle, Molière, Fanny, Courtet, Philippe, Galtier, Florence, Richieri, Raphaëlle-Marie, Morange, Sophie, Llorca, Pierre-Michel, El-Hage, Wissam, Desmidt, Thomas, Haesebaert, Frédéric, Vignaud, Philippe, Holtzmann, Jerôme, Cracowski, Jean-Luc, Leboyer, Marion, Yrondi, Antoine, Calvas, Fabienne, Yon, Liova, Le Corvoisier, Philippe, Doumy, Olivier, Heron, Kyle, Montange, Damien, Davani, Siamak, Déglon, Julien, Besson, Marie, Desmeules, Jules, Haffen, Emmanuel, Bellivier, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678760/
https://www.ncbi.nlm.nih.gov/pubmed/29115994
http://dx.doi.org/10.1186/s40360-017-0173-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678760/
https://www.ncbi.nlm.nih.gov/pubmed/29115994
http://dx.doi.org/10.1186/s40360-017-0173-2

Ejemplares similares